 |
 |
 |
| PAIN MANAGEMENT RELATED ARTICLES |
| Title (Click for Details) |
Vol/Issue |
Page |
| Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion |
Vol. 15 No. 6 |
504 |
| Magic Mouthwashes: A Literature Review and Discussion of Common Compositions |
Vol. 15 No. 5 |
376 |
| Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient |
Vol. 15 No. 5 |
386 |
| Transdermals: The Skin as Part of a Drug Delivery System |
Vol. 15 No. 4 |
308 |
| Anesthetic Nasal Ointment |
Vol. 15 No. 4 |
334 |
| Oxandrolone 1-mg/mL Oral Suspension |
Vol. 15 No. 4 |
341 |
| Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient |
Vol. 15 No. 3 |
194 |
| Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel |
Vol. 15 No. 3 |
242 |
| Diclofenac Sodium 1% Topical Gel |
Vol. 15 No. 3 |
243 |
| Ibuprofen 5% Topical Cream |
Vol. 15 No. 3 |
244 |
| Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel |
Vol. 15 No. 3 |
245 |
| Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel |
Vol. 15 No. 2 |
157 |
| PostScription: Commentary: Discussion on the Safety of Topical Prilocaine |
Vol. 15 No. 2 |
174 |
| Current Concepts in the Treatment of Recurrent Aphthous Ulcers |
Vol. 15 No. 1 |
13 |
| Toxicities Associated with Topical Anesthetics |
Vol. 15 No. 1 |
41 |
| Diclofenac Sodium 10-mg/mL Oral Suspension |
Vol. 15 No. 1 |
64 |
| Ibuprofen 5% Gel |
Vol. 15 No. 1 |
66 |
| Piroxicam 1% Gel |
Vol. 15 No. 1 |
69 |
| Pramoxine 1% Cream |
Vol. 15 No. 1 |
70 |
| All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding |
Vol. 14 No. 6 |
484 |
| Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
512 |
| Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
513 |
| Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
514 |
| Capsaicin 0.05% Clear Medication Stick |
Vol. 14 No. 6 |
517 |
| Ketoprofen 2% Oral Gel |
Vol. 14 No. 6 |
521 |
| "My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care |
Vol. 14 No. 6 |
480 |
| Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel |
Vol. 14 No. 6 |
520 |
| Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients |
Vol. 14 No. 5 |
395 |
| Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection |
Vol. 14 No. 5 |
427 |
| Polidocanol 0.5% Wound Spray |
Vol. 14 No. 5 |
429 |
| Acyclovir with Benzocaine Lip Balm |
Vol. 14 No. 4 |
332 |
| Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone |
Vol. 14 No. 4 |
333 |
| Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser |
Vol. 14 No. 4 |
310 |
| Buprenorphine Hydrochloride Injection |
Vol. 14 No. 4 |
337 |
| Chloroprocaine Hydrochloride Injection |
Vol. 14 No. 4 |
338 |
| Flurbiprofen 5% Bioadhesive Gel for Gingivitis |
Vol. 14 No. 4 |
341 |
| Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome |
Vol. 14 No. 3 |
182 |
| Topical Medications for Orofacial Neuropathic Pain |
Vol. 14 No. 3 |
200 |
| Managing Pain with Transdermal Ketoprofen |
Vol. 14 No. 3 |
204 |
| Potential Treatments for Radiation Dermatitis |
Vol. 14 No. 3 |
210 |
| Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report |
Vol. 14 No. 3 |
215 |
| Calculations |
Vol. 14 No. 3 |
230 |
| Carprofen 2.5-mg/mL Oral Suspension, Veterinary |
Vol. 14 No. 3 |
241 |
| Celecoxib 10-mg/mL Oral Suspension |
Vol. 14 No. 3 |
242 |
| The Role of Sex Hormones on Fibromyalgia Pain Mediators |
Vol. 14 No. 3 |
193 |
| Cohen's Rectal Ointment |
Vol. 14 No. 3 |
244 |
| Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector |
Vol. 14 No. 2 |
160 |
| Tetracaine 4% and Menthol 5% Topical Gel |
Vol. 14 No. 1 |
73 |
| Trigger Point Gel |
Vol. 14 No. 1 |
75 |
| Topiramate 6-mg/mL Oral Suspension |
Vol. 13 No. 6 |
560 |
| Aceclofenac 1.5% Pluronic Lecithin Organogel |
Vol. 13 No. 5 |
428 |
| An Abridged History of Aspirin |
Vol. 13 No. 5 |
404 |
| Lidocaine 10% Oral Pluronic Lecithin Organogel |
Vol. 13 No. 5 |
433 |
| Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications |
Vol. 13 No. 5 |
400 |
| Update on Managing Neuropathic Pain |
Vol. 13 No. 3 |
182 |
| Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids |
Vol. 13 No. 3 |
192 |
| Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report |
Vol. 13 No. 3 |
196 |
| Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers |
Vol. 13 No. 3 |
214 |
| Safe Use of Topical Local Anesthetic Medications for Pain Management |
Vol. 13 No. 3 |
218 |
| Calculations |
Vol. 13 No. 3 |
239 |
| Analgesic Compound Lotion, Clear |
Vol. 13 No. 3 |
240 |
| Hydromorphone Hydrochloride 10-mg/mL Oral Drops |
Vol. 13 No. 3 |
241 |
| Lidocaine 2% Popsicle |
Vol. 13 No. 3 |
242 |
| Morphine Sulfate 10-mg/mL Oral Solution |
Vol. 13 No. 3 |
243 |
| Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel |
Vol. 13 No. 3 |
244 |
| Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel |
Vol. 13 No. 3 |
245 |
| Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules |
Vol. 13 No. 3 |
246 |
| Oxycodone Hydrochloride 20-mg Suppository |
Vol. 13 No. 3 |
247 |
| Promethazine 20-mg and Acetaminophen 325-mg Suppositories |
Vol. 13 No. 3 |
248 |
| Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules |
Vol. 13 No. 3 |
249 |
| Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel |
Vol. 13 No. 1 |
66 |
| Tetracaine 0.025% Popsicles |
Vol. 13 No. 1 |
73 |
| Equine Anesthesia: Triple Drip |
Vol. 12 No. 5 |
402 |
| Aceclofenac 1.5% Gel-Cream |
Vol. 12 No. 5 |
446 |
| Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration |
Vol. 12 No. 5 |
463 |
| Acetaminophen 10-mg/mL Rectal Solution |
Vol. 12 No. 5 |
447 |
| Ketoprofen 20% Topical Solution |
Vol. 12 No. 5 |
452 |
| Lidocaine Adhesive System Gel |
Vol. 12 No. 5 |
453 |
| Piroxicam 5% and Dexpanthenol 5% Gel |
Vol. 12 No. 5 |
454 |
| Case Reports: Compounding to Relieve Arthritis Pain |
Vol. 12 No. 6 |
498 |
| Glycerin, Sterile |
Vol. 12 No. 6 |
542 |
| Indomethacin 2% in Pluronic Lecithin Organogel |
Vol. 12 No. 6 |
543 |
| Ketorolac Tromethamine 2% Topical Gel |
Vol. 12 No. 6 |
544 |
| Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel |
Vol. 12 No. 6 |
540 |
| Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel |
Vol. 12 No. 6 |
541 |
| Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches |
Vol. 12 No. 6 |
549 |
| Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration |
Vol. 12 No. 6 |
553 |
| Standard Operating Procedure: Dealing with Patients Experiencing Pain: Presenting without a Prescription |
Vol. 12 No. 3 |
259 |
| Potassium Nitrate/Benzocaine/Tetracaine Dental Gel |
Vol. 12 No. 3 |
266 |
| PreScription: Pain! |
Vol. 12 No. 3 |
180 |
| Topical Treatment of Neuropathic Pain |
Vol. 12 No. 3 |
182 |
| Compounded Local Anesthetics to Minimize Pain from Medical Procedures |
Vol. 12 No. 3 |
192 |
| Dilution and Compounding of Ziconotide for Intrathecal Administration |
Vol. 12 No. 3 |
200 |
| Developing a Niche Marketing Strategy |
Vol. 12 No. 3 |
242 |
| Chemical Stability of Tramadol Hydrochloride Injection |
Vol. 12 No. 2 |
161 |
| Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting |
Vol. 12 No. 2 |
163 |
| Carbamazepine Topical Preparations |
Vol. 12 No. 2 |
150 |
| Hospice and Compounding Pharmacy: Once Inseperable |
Vol. 12 No. 1 |
28 |
| Diclofenac Sodium 1% Soft-Patch Gel |
Vol. 12 No. 1 |
65 |
| Diclofenac Sodium 1% Soft-Patch Lipophilic Gel |
Vol. 12 No. 1 |
66 |
| Flosulide 10-mg/mL Injection |
Vol. 12 No. 1 |
69 |
| Piroxicam 1% Soft-Patch Lipophilic Gel |
Vol. 12 No. 1 |
71 |
| Piroxicam 1% Soft-Patch Topical Gel |
Vol. 12 No. 1 |
72 |
| Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen |
Vol. 11 No. 6 |
514 |
| Lidocaine Hydrochloride 1.82% Buffered Injection |
Vol. 11 No. 6 |
511 |
| Rabbit Medicine |
Vol. 11 No. 5 |
364 |
| Diclofenac Sodium 75-mg/mL Injection |
Vol. 11 No. 5 |
421 |
| Hydrocortisone 0.5% Ethanolic Gel |
Vol. 11 No. 5 |
423 |
| Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution |
Vol. 11 No. 4 |
328 |
| Mebeverine Hydrochloride 20% gel |
Vol. 11 No. 4 |
330 |
| Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution |
Vol. 11 No. 4 |
335 |
| Levorphanol for Excruciating Pain from Oral Cancer: A Case Report |
Vol. 11 No. 3 |
212 |
| Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 |
Vol. 11 No. 3 |
220 |
| Calculations - Compounding for Pain Management |
Vol. 11 No. 3 |
238 |
| Transdermal Gel in the Treatment of Postoperative Pain |
Vol. 11 No. 3 |
181 |
| Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited |
Vol. 11 No. 3 |
187 |
| The Rectal Rocket: A Two-Day Treatment for Hemorrhoids |
Vol. 11 No. 3 |
194 |
| Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain |
Vol. 11 No. 3 |
200 |
| Levorphanol for the Treatment of Severe Chronic Pain |
Vol. 11 No. 3 |
202 |
| Aspirin 80-mg/5-mL Oral Liquid, Anhydrous |
Vol. 11 No. 2 |
154 |
| Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster |
Vol. 11 No. 2 |
131 |
| Principles of Pediatric Palliative Care and Pain Control |
Vol. 11 No. 1 |
10 |
| Clonidine Hydrochloride 0.1-mg/mL Oral Liquid |
Vol. 11 No. 1 |
71 |
| Dexamethasone 1-mg/mL Oral Liquid |
Vol. 11 No. 1 |
72 |
| Chloral Hydrate 50-mg/mL Oral Liquid |
Vol. 10 No. 6 |
453 |
| Gabapentin 100-mg/mL Oral Liquid |
Vol. 10 No. 6 |
456 |
| Indomethacin 2-mg/mL Oral Liquid |
Vol. 10 No. 6 |
458 |
| Migraine: A General Approach to Prevention and Treatment |
Vol. 10 No. 5 |
344 |
| Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches |
Vol. 10 No. 5 |
351 |
| Midazolam Hydrochloride 1-mg/mL Oral Liquid |
Vol. 10 No. 5 |
387 |
| Hospice Symptom Relief Kit: An Update |
Vol. 10 No. 4 |
288 |
| Tramadol Hydrochloride 5-mg/mL Oral Liquid |
Vol. 10 No. 4 |
307 |
| Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid |
Vol. 10 No. 4 |
308 |
| Mexiletine Hydrochloride 10-mg/mL Oral Suspension |
Vol. 10 No. 3 |
225 |
| Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together |
Vol. 10 No. 3 |
237 |
| Chemical Stability of Diclofenac Sodium Injection |
Vol. 10 No. 2 |
154 |
| PostScription: Treatment of Chronic Pain with Methadone or Levorphanol |
Vol. 10 No. 2 |
159 |
| Hospice from a Compounding Pharmacist's Perspective |
Vol. 10 No. 2 |
89 |
| Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh |
Vol. 10 No. 1 |
9 |
| Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery |
Vol. 10 No. 1 |
14 |
| Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid |
Vol. 10 No. 1 |
66 |
| Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management |
Vol. 10 No. 1 |
69 |
| Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags |
Vol. 9 No. 6 |
482 |
| Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain |
Vol. 9 No. 5 |
339 |
| Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain |
Vol. 9 No. 5 |
349 |
| A Patient's Guide to Transdermal Treatment of Pain |
Vol. 9 No. 5 |
354 |
| Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules |
Vol. 9 No. 5 |
386 |
| Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules |
Vol. 9 No. 5 |
387 |
| Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules |
Vol. 9 No. 5 |
388 |
| Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules |
Vol. 9 No. 5 |
389 |
| Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection |
Vol. 9 No. 5 |
390 |
| Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules |
Vol. 9 No. 5 |
391 |
| Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules |
Vol. 9 No. 5 |
392 |
| Methadone Hydrochloride 0.33-mg/mL Oral Solution |
Vol. 9 No. 5 |
393 |
| Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection |
Vol. 9 No. 5 |
394 |
| Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) |
Vol. 9 No. 5 |
395 |
| Bonain's Solution |
Vol. 9 No. 4 |
311 |
| Brompton's Mixture |
Vol. 9 No. 4 |
312 |
| Dexamethasone Oral Powder 10-mg Units, Veterinary |
Vol. 9 No. 3 |
226 |
| Dipyrone 500-mg/mL Injection, Veterinary |
Vol. 9 No. 3 |
227 |
| Meloxicam 0.2 mg/mL Oral Liquid, Veterinary |
Vol. 9 No. 3 |
228 |
| Piroxicam 2-mg/mL Oral Liquid, Veterinary |
Vol. 9 No. 3 |
234 |
| Capsaicin 0.2-mg Troches |
Vol. 9 No. 2 |
148 |
| Clobetasol and Dyclonine Oral Paste |
Vol. 9 No. 2 |
150 |
| In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride |
Vol. 9 No. 2 |
157 |
| Amitriptyline Hydrochloride 10-mg/mL Injection |
Vol. 9 No. 1 |
62 |
| Fentanyl 15-mg/mL Injection, Preservative Free |
Vol. 9 No. 1 |
63 |
| Gabapentin 2-mg/mL Injection, Preservative Free |
Vol. 9 No. 1 |
64 |
| Lidocaine Hydrochloride-2%, Ketolorac Tromethamine-3%, and Clonidine Hydrochloride-0.1% Injection |
Vol. 9 No. 1 |
66 |
| Naproxen Sodium 100-mg/mL Injection |
Vol. 9 No. 1 |
68 |
| Phenol 8% Injection |
Vol. 9 No. 1 |
69 |
| Tolazoline Hydrochloride 25-mg/mL Injection |
Vol. 9 No. 1 |
70 |
| Tramadol Hydrochloride 50-mg/mL Injection, Preservative Free |
Vol. 9 No. 1 |
71 |
| Compounding for Sports Medicine |
Vol. 8 No. 6 |
443 |
| Diclofenac Sodium 25-mg/mL Injection |
Vol. 8 No. 6 |
470 |
| Ketamine Hydrochloride and Fentanyl Citrate Injection |
Vol. 8 No. 6 |
474 |
| Ketamine 25-mg/mL Nasal Spray |
Vol. 8 No. 6 |
475 |
| Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray |
Vol. 8 No. 6 |
476 |
| Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink |
Vol. 8 No. 6 |
489 |
| Book and Literature Reviews |
Vol. 8 No. 5 |
324 |
| Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications |
Vol. 8 No. 5 |
337 |
| Diclofenac Sodium 1.5% Topical Gel |
Vol. 8 No. 5 |
387 |
| Ibuprofen 2% Topical Gel |
Vol. 8 No. 5 |
388 |
| Book and Literature Reviews |
Vol. 8 No. 4 |
244 |
| Migraine Headache Suppositories |
Vol. 8 No. 3 |
184 |
| Dicyclomine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches |
Vol. 8 No. 3 |
184 |
| Morphine Sulfate 5-mg/0.1-mL Nasal Spray |
Vol. 8 No. 3 |
185 |
| Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) |
Vol. 8 No. 3 |
185 |
| Pain Management in the Elderly |
Vol. 8 No. 3 |
187 |
| Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medication Stick (Water-soluble base) |
Vol. 8 No. 3 |
208 |
| Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medications Stick (Water-proof base) |
Vol. 8 No. 3 |
208 |
| Emollient Lip Balm with 5% Benzocaine |
Vol. 8 No. 3 |
208 |
| Fever Blister Ointment |
Vol. 8 No. 3 |
208 |
| Deoxy-D-Glucose 0.2%, Lidocaine HCl 5% and Sodium Lauryl Sulfate 5% Cream |
Vol. 8 No. 3 |
208 |
| Acyclovir 5% and Lidocaine HCl 2% Topical Gel |
Vol. 8 No. 3 |
209 |
| Acyclovir 5% and Sodium Lauryl Sulfate 5% Topical Gel |
Vol. 8 No. 3 |
209 |
| Acyclovir 5% and Dexamethasone 0.1% Topical Gel |
Vol. 8 No. 3 |
209 |
| Foscarnet 3% and Triamcinolone Acetonide 0.1% Topical Gel |
Vol. 8 No. 3 |
209 |
| Clonidine HCl 1.5-mg/mL Injection |
Vol. 8 No. 3 |
216 |
| Ketoprofen 50-mg Suppository |
Vol. 8 No. 3 |
219 |
| Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection |
Vol. 8 No. 3 |
220 |
| Sumatriptan 25-mg Suppository |
Vol. 8 No. 3 |
221 |
| Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs |
Vol. 8 No. 2 |
101 |
| Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection |
Vol. 8 No. 2 |
136 |
| Sore Nipples in Breastfeeding Mothers: Causes and Treatments |
Vol. 7 No. 6 |
426 |
| Methadone HCl 2.5-mg Capsules |
Vol. 7 No. 6 |
472 |
| Tramadol HCl 100-mg Capsules |
Vol. 7 No. 6 |
475 |
| Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers |
Vol. 7 No. 6 |
481 |
| Indomethacin 50-mg Suppositories |
Vol. 7 No. 5 |
375 |
| Pentazocine HCl 12.5-mg and Aspirin 325-mg Capsules |
Vol. 7 No. 5 |
377 |
| Phenylbutazone 100-mg Capsules |
Vol. 7 No. 5 |
379 |
| Basics of Compounding for Raynaud's Disease |
Vol. 7 No. 4 |
288 |
| Meperidine HCl 100-mg/mL and Atropine Sulfate 0.4-mg/mL Injection |
Vol. 7 No. 4 |
300 |
| Meperidine HCl 25-mg/mL and Promethazine HCl 25-mg/mL Injection |
Vol. 7 No. 4 |
301 |
| Methocarbamol 400-mg and Aspirin 325-mg Capsules |
Vol. 7 No. 4 |
302 |
| The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP |
Vol. 7 No. 3 |
180 |
| Dexamethasone Phosphate 0.1% Topical Cream |
Vol. 7 No. 3 |
216 |
| Ergotamine Tartrate 2-mg Sublingual Tablets |
Vol. 7 No. 3 |
219 |
| Methadone HCl 5-mg/mL Injection |
Vol. 7 No. 3 |
221 |
| Ketoprofen 10% in PLO |
Vol. 7 No. 3 |
183 |
| Ketamine 10 %, Gabapentin 6%, and Nifedipine 2% in PLO |
Vol. 7 No. 3 |
171 |
| PostScription: Sterile Product Admixture Preparation |
Vol. 7 No. 2 |
160 |
| Dexamethasone Sodium Phosphate 4-mg/mL Injection |
Vol. 6 No. 6 |
450 |
| Hydromorphone HCl 0.1-mg/mL Injection for Patient-Controlled Analgesia |
Vol. 6 No. 6 |
454 |
| Methadone HCl 1-mg/mL, 2-mg/mL, and 5-mg/mL Injection |
Vol. 6 No. 6 |
455 |
| Morphine Sulfate 2-mg/mL and Droperidol 0.08-mg/mL Injection for Patient-Controlled Analgesia |
Vol. 6 No. 6 |
456 |
| Drug Therapy for Acute and Chronic Pain in the Cat |
Vol. 6 No. 5 |
338 |
| Basics of Compounding: Phonophoresis |
Vol. 6 No. 5 |
362 |
| Ketoprofen 2% Gel for Phonophoresis |
Vol. 6 No. 5 |
364 |
| Naproxen 5% Gel for Phonophoresis |
Vol. 6 No. 5 |
364 |
| Sodium Salicylate 10% Gel for Phonophoresis |
Vol. 6 No. 5 |
364 |
| Hydrocortisone 10% Gel for Phonophoresis |
Vol. 6 No. 5 |
364 |
| Dexamethasone 1.5% and Lidocaine HCl 4% Ultrasound Gel |
Vol. 6 No. 5 |
365 |
| Ketoprofen 10% in Pluronic Lecithin Organogel |
Vol. 6 No. 5 |
368 |
| Basics of Compounding for Iontophoresis, Part II |
Vol. 6 No. 4 |
288 |
| Lidocaine HCl 4% Solution for Iontophoresis |
Vol. 6 No. 4 |
290 |
| Dexamethasone 4-mg/mL Solution for Iontophoresis |
Vol. 6 No. 4 |
290 |
| Acetic Acid 2% Solution for Iontophoresis |
Vol. 6 No. 4 |
290 |
| Ketorolac 6-mg/mL Solution for Iontophoresis |
Vol. 6 No. 4 |
291 |
| Treatment of Pain with a Topically Applied Combination of Indomethacin and Piroxicam |
Vol. 6 No. 3 |
189 |
| Basics of Compounding: Iontophoresis, Part 1 |
Vol. 6 No. 3 |
194 |
| Camphor, Menthol, and Eucalyptol Rubefacient Ointment |
Vol. 6 No. 3 |
201 |
| Ergoloid Mesylates 15-mg/mL and Selegiline HCl 6.25-mg/mL in PLO |
Vol. 6 No. 3 |
203 |
| Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance |
Vol. 6 No. 1 |
4 |
| Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective |
Vol. 6 No. 1 |
13 |
| Excerpts from and Reviews of Current Published Literature: Pain Management and Disorders of the Oral Cavity |
Vol. 6 No. 1 |
19 |
| Analgesic NSAID Suppositories |
Vol. 6 No. 1 |
40 |
| Capsaicin 0.075% Topical Spray |
Vol. 6 No. 1 |
41 |
| Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO) |
Vol. 6 No. 1 |
42 |
| Diltiazem HCl 2% Topical Gel |
Vol. 6 No. 1 |
43 |
| Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection |
Vol. 6 No. 1 |
44 |
| Fentanyl 100-mcg/0.1-mL in a Pluronic Lecithin Organogel (PLO) |
Vol. 6 No. 1 |
45 |
| Ketoprofen 12.5-mg, Phenyltoloxamine Citrate 30-mg, and Caffeine 30-mg Capsules |
Vol. 6 No. 1 |
46 |
| Morphine Sulfate 0.01%-Infused Silver Sulfadiazine (MISS) Cream |
Vol. 6 No. 1 |
47 |
| Morphine Sulfate 5-mg/0.1-mL Nasal Spray |
Vol. 6 No. 1 |
48 |
| Oxycodone 25-mg Slow-Release Capsules |
Vol. 6 No. 1 |
49 |
| Hydrocortisone 10% Phonophoresis Gel |
Vol. 5 No. 6 |
454 |
| Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution |
Vol. 5 No. 6 |
455 |
| Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release |
Vol. 5 No. 5 |
401 |
| Sclerotherapy Injections of Phenol for Pain Management |
Vol. 5 No. 4 |
308 |
| PostScription: Case Reports and Formulations, George Roentsch, RPh. |
Vol. 5 No. 2 |
160 |
| Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel |
Vol. 5 No. 1 |
44 |
| Fentanyl Troche Protocol |
Vol. 4 No .6 |
447 |
| Capsicum Oleoresin 0.3% and Ketoprofen 10% in PLO Gel |
Vol. 4 No. 5 |
377 |
| Ketamine for Pain in Hospice Patients |
Vol. 4 No. 4 |
253 |
| Custom-Making Medications for the Hospice Patient |
Vol. 4 No. 4 |
255 |
| Surviving Cancer - How the Compounding Pharmacist Can Help |
Vol. 4 No. 4 |
257 |
| Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO |
Vol. 4 No. 4 |
299 |
| Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution |
Vol. 4 No. 4 |
300 |
| Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers |
Vol. 4 No. 4 |
301 |
| Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection |
Vol. 4 No. 4 |
303 |
| Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs |
Vol. 4 No. 4 |
318 |
| Ketamine HCl 5% and Amitriptyline HCl 2% in PLO |
Vol. 4 No. 2 |
132 |
| Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO |
Vol. 4 No. 2 |
133 |
| Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium |
Vol. 4 No. 1 |
6 |
| The Psychology of Pain |
Vol. 4 No. 1 |
12 |
| Opioids: A Review of the Pharmacology |
Vol. 4 No. 1 |
17 |
| Fibromyalgia |
Vol. 4 No. 1 |
21 |
| Compounding Intrathecal Medications |
Vol. 4 No. 1 |
24 |
| Postherpetic Neuralgia |
Vol. 4 No. 1 |
27 |
| Amitriptyline HCl 2% and Baclofen 2% in PLO |
Vol. 4 No. 1 |
50 |
| Capsaicin 0.075%, Ketamine HCl 2% and Ketoprofen 10% in PLO |
Vol. 4 No. 1 |
51 |
| Capsicum 0.32%, Methyl Salicylate 25% and Menthol 10% Analgesic Cream |
Vol. 4 No. 1 |
52 |
| Clonidine HCl 1-mg/g in VanPen Cream |
Vol. 4 No. 1 |
53 |
| Cyclobenzaprine 1% and Guaifenesin 10% in Speed Gel |
Vol. 4 No. 1 |
54 |
| Dyclonine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches |
Vol. 4 No. 1 |
55 |
| Fentanyl 50-mcg Chewable Gummy Gels |
Vol. 4 No. 1 |
56 |
| Fentanyl 25-mcg/0.1-mL Nasal Spray |
Vol. 4 No. 1 |
57 |
| Morphine Sulfate 2.5-mg/mL Inhalation Solution |
Vol. 4 No. 1 |
58 |
| Shingles Ointment/Cream |
Vol. 4 No. 1 |
59 |
| Osteoarthritis: Other Options |
Vol. 3 No. 6 |
433 |
| Case Reports for Arthritis Issue: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player |
Vol. 3 No. 6 |
441 |
| Iontophoresis and Phonophoresis for Treating Epicondylitis |
Vol. 3 No. 6 |
441 |
| Capsicum and Capsaicin Formulas |
Vol. 3 No. 6 |
468 |
| DMSO 70% Topical Solution |
Vol. 3 No. 6 |
469 |
| Glucosamine HCl 600-mg Capsules |
Vol. 3 No. 6 |
470 |
| Indomethacin 4% Topical Spray |
Vol. 3 No. 6 |
471 |
| Iontophoresis Solutions for Arthritis |
Vol. 3 No. 6 |
472 |
| Ketoprofen 2.5% in Pluronic Lecithin Organogel |
Vol. 3 No. 6 |
473 |
| Methyl Salicylate and Menthol Analgesic Stick |
Vol. 3 No. 6 |
475 |
| Piroxicam 1% Alcoholic Gel |
Vol. 3 No. 6 |
476 |
| Ultrasonic Preparations for Arthritis |
Vol. 3 No. 6 |
477 |
| Compounding for Athletes: Successful Sports Compounds |
Vol. 3 No. 5 |
382 |
| The Basics of Compounding: Compounding Gels |
Vol. 3 No. 5 |
385 |
| Piroxicam 0.5% in an Alcoholic Gel |
Vol. 3 No. 5 |
389 |
| Pluronic Lecithin Organogel (PLO Gel) |
Vol. 3 No. 5 |
389 |
| In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules |
Vol. 3 No. 5 |
409 |
| Fentanyl 20-mcg/mL and Bupivacaine HCl 1.25-mg/mL for Pump Administration |
Vol. 3 No. 4 |
301 |
| Morphine Sulfate 50-mg/mL Injection |
Vol. 3 No. 4 |
302 |
| Rapid Pharmacokinetic Evaluation of Topical Drug Formulations |
Vol. 3 No. 4 |
321 |
| Compounding for Athletes: Tips for Making the Team |
Vol. 3 No. 3 |
206 |
| Morphine Sulfate-Dextromethorphan Hydrobromide-Example of capsule with Dry Powder Fill |
Vol. 3 No. 3 |
215 |
| Compounding for Athletes: A Primer for Rookies |
Vol. 3 No. 2 |
104 |
| The Basics of Compounding: Compounding Creams and Lotions |
Vol. 3 No. 2 |
111 |
| Athletic-Analgesic Rub |
Vol. 3 No. 2 |
130 |
| Piroxicam 0.5% in Pluronic Lecithin Organogel |
Vol. 3 No. 2 |
133 |
| The Basics of Compounding: Compounding Ointments and Pastes |
Vol. 3 No. 1 |
22 |
| Topical Ketoprofen for Fibromyalgia |
Vol. 2 No. 6 |
433 |
| Ketorolac tromethamine and Ketoprofen suppositories: release profiles and bioavailability of cocoa butter base formula in rabbits |
Vol. 2 No. 5 |
390 |
| Antipruritus Suspension (Stop Itch) |
Vol. 2 No. 4 |
277 |
| Benzocaine 2% Anesthetic Gel |
Vol. 2 No. 4 |
296 |
| Cocaine-Phenol-Tannic Acid Ointment |
Vol. 2 No. 4 |
298 |
| Compounding for Pain Management |
Vol. 2 No. 2 |
104 |
| Opioids for Noncancer Pain: From Controversy to Consensus |
Vol. 2 No. 2 |
106 |
| Phonophoresis with Hydrocortisone 10% in a Highly Viscous Complant Base |
Vol. 2 No. 2 |
110 |
| Managing Pain in the Terminally Ill |
Vol. 2 No. 2 |
111 |
| The Symptom Relief Kit for Hospice Patients |
Vol. 2 No. 2 |
116 |
| Dextromethorphan Hydrobromide and Opioid Tolerance: A Compounding Opportunity for Pharmacists with Chronic Pain Patients |
Vol. 2 No. 2 |
118 |
| Profile of a Practice/Patient Handout: DHE Nasal Spray |
Vol. 2 No. 2 |
120 |
| Clinical Application of Ketamine Ointment in the Treatment of Sympathetically Maintained Pain |
Vol. 2 No. 2 |
122 |
| Buprenorphine HCl 150-mcg/100 mcL Nasal Spray |
Vol. 2 No. 2 |
145 |
| Capsaicin 0.05% Topical Gel |
Vol. 2 No. 2 |
146 |
| Dexamethasone Sodium Phosphate 1-mg/mL for Iontophoresis |
Vol. 2 No. 2 |
147 |
| Dextromethorphan Hydrobromide 30-mg and Morphine Sulfate 10-mg Capsules |
Vol. 2 No. 2 |
148 |
| Dihydroergotamine Mesylate 2.5-mg/mL Nasal Spray |
Vol. 2 No. 2 |
149 |
| Dihydroergotamine Mesylate 1-mg Troches |
Vol. 2 No. 2 |
150 |
| Ergotamine Tartrate, Caffeine, Hyoscyamine Sulfate and Pentobarbital Sodium Suppositories |
Vol. 2 No. 2 |
151 |
| Fentanyl 50-mcg Chewable Gummy Gels |
Vol. 2 No. 2 |
152 |
| Fentanyl 300-mcg/6-mL Inhalation |
Vol. 2 No. 2 |
153 |
| Ketoprofen 10%, Cyclobenzaprine 1% and Lidocaine 5% in Poloxamer Lecithin Organogel |
Vol. 2 No. 2 |
154 |
| Lidocaine 30% Lip Balm |
Vol. 2 No. 2 |
155 |
| Meperidine HCl 50-mg/mL Nasal Solution |
Vol. 2 No. 2 |
156 |
| Morphine Sulfate 25-mg Troche |
Vol. 2 No. 2 |
157 |
| Sumatriptan 5-mg/mL Oral Liquid |
Vol. 2 No. 2 |
158 |
| Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel |
Vol. 2 No. 2 |
159 |
| Dexamethasone and Lidocaine Solution for Iontophoresis |
Vol. 1 No. 6 |
410 |
| Ketorolac Solution for Iontophoresis |
Vol. 1 No. 6 |
415 |
| Lidocaine HCl 2% Solution for Iontophoresis |
Vol. 1 No. 6 |
416 |
| Morphine 10-mg Troches |
Vol. 1 No. 6 |
417 |
| Iontophoresis Devices: Clinical Applications for Topical Delivery |
Vol. 1 No. 6 |
420 |
| Fentanyl-Bupivacaine-Epinephrine for Epidural Analgesia |
Vol. 1 No. 5 |
325 |
| Hydromorphone HCl 10-, 25-, and 50-mg/mL Injections |
Vol. 1 No. 5 |
327 |
| Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection |
Vol. 1 No. 5 |
328 |
| Morphine Sulfate-Bupivacaine HCl Injection |
Vol. 1 No. 5 |
330 |
| Morphine Sulfate 10-, 25-, and 50-mg/mL Injections (Preservative Free) |
Vol. 1 No. 5 |
331 |
| Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease |
Vol. 1 No. 4 |
242 |
| Beclomethasone Dipropionate 1.25 mg/mL Aerosol Solution-Veterinary |
Vol. 1 No. 4 |
243 |
| Fentanyl and Bupivacaine Injection for Ambulatory Pump Reservoir |
Vol. 1 No. 3 |
178 |
| Piroxicam 2% in an Alcoholic Gel |
Vol. 1 No. 3 |
181 |
| Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections |
Vol. 1 No. 3 |
206 |
| Rectal and Stomal Administration of Analgesic Suppositories |
Vol. 1 No. 1 |
12 |
| Morphine Sulfate Slow-Release Suppositories |
Vol. 1 No. 1 |
32 |
| Morphine Suppositories |
Vol. 1 No. 1 |
36 |